Clinical Trials in Uijeongbu-si, South Korea
Locations / Uijeongbu-si, South Korea
Delta Trials records 165 clinical trials conducted in Uijeongbu-si, South Korea, making it a notable site of clinical research activity. These trials across 188 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 7 trials in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Uijeongbu-si has changed over time.
165
Total Trials
188
Conditions
7
Terminated since 2020
Browse by condition (188 total)
- Coronary artery disease 16 trialsAll Coronary artery disease trials
- Diabetes mellitus, type 2 6 trialsAll Diabetes mellitus, type 2 trials
- Myocardial infarction 4 trialsAll Myocardial infarction trials
- Asthma 4 trialsAll Asthma trials
- Breast cancer 4 trialsAll Breast cancer trials
- All Chronic obstructive pulmonary disease trials
- Stroke 3 trialsAll Stroke trials
- Type 2 diabetes 3 trialsAll Type 2 diabetes trials
- Chronic myelogenous leukemia 3 trialsAll Chronic myelogenous leukemia trials
- Migraine 3 trialsAll Migraine trials
- Heart failure 3 trialsAll Heart failure trials
- Out-of-hospital cardiac arrest 2 trialsAll Out-of-hospital cardiac arrest trials
- Anaemia 2 trialsAll Anaemia trials
- Mild cognitive impairment 2 trialsAll Mild cognitive impairment trials
- Type 2 diabetes mellitus 2 trialsAll Type 2 diabetes mellitus trials
- Chronic kidney disease 2 trialsAll Chronic kidney disease trials
- Chronic myeloid leukemia 2 trialsAll Chronic myeloid leukemia trials
- Hepatitis c virus 2 trialsAll Hepatitis c virus trials
- Acute coronary syndrome 2 trialsAll Acute coronary syndrome trials
- Hypertension 2 trialsAll Hypertension trials